About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Ralgapa2tm1Hhor
targeted mutation 1, H Horiuchi
MGI:5469375
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Ralgapa2tm1Hhor/Ralgapa2tm1Hhor C57BL/6J-Ralgapa2tm1Hhor MGI:5469376


Genotype
MGI:5469376
hm1
Allelic
Composition		 Ralgapa2tm1Hhor/Ralgapa2tm1Hhor
Genetic
Background		 C57BL/6J-Ralgapa2tm1Hhor
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ralgapa2tm1Hhor mutation (0 available); any Ralgapa2 mutation (116 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased incidence of tumors by chemical induction ( J:193368 )
• all N-butyl-N-(4-hydroxybutyl) nitrosamine-treated develop invasive urothelial bladder tumors unlike wild-type mice
increased urinary system tumor incidence ( J:193368 )
• all N-butyl-N-(4-hydroxybutyl) nitrosamine-treated develop invasive urothelial bladder tumors unlike wild-type mice

homeostasis/metabolism
increased incidence of tumors by chemical induction ( J:193368 )
• all N-butyl-N-(4-hydroxybutyl) nitrosamine-treated develop invasive urothelial bladder tumors unlike wild-type mice

renal/urinary system
increased urinary system tumor incidence ( J:193368 )
• all N-butyl-N-(4-hydroxybutyl) nitrosamine-treated develop invasive urothelial bladder tumors unlike wild-type mice




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
09/30/2025
MGI 6.24 		The Jackson Laboratory